Innovation & IP

OTC Marketing Awards 2025: What The Judges Said About The Leading Entries

 
• By 

The trophies have been presented at the OTC Marketing Awards 2025 - but what did the judging panel have to say about the winning and highly-commended entries?

Opella Takes Top Prize At OTC Marketing Awards 2025

 
• By 

Winners across 12 categories were announced at the OTC Marketing Awards 2025 on 20 November, with Opella crowned OTC Company of the Year.

Over The Counter Special: Unlocking Switch-Driven Growth, With PAGB’s Michelle Riddalls

 
• By 

Self-Care Week Special: HBW Insight catches up with PAGB CEO Michelle Riddalls OBE to talk about what the association is doing to promote Rx-to-OTC switch in the UK.

Bayer: Product Launches Alone ‘Not Enough’ To Meet Women’s Health Needs

 
• By 

“It’s not good enough just to provide products anymore, we need to create a service and a holistic approach to products,” argued Bayer Consumer Health's Northern Europe general manager, Mike Knowland, speaking at a recent panel event in the UK Parliament.


Karo To Grow Lamisil In Europe With ‘Next Generation’ Fungal Nail Treatment

 
• By 

Karo will take on responsibility for the marketing, distribution and sales of Moberg’s topical onychomycosis treatment, MOB-15, under the Lamisil brand in 19 European countries.

The Global Allergy Market In 2025: ‘Growth Is Back, But Not Like Before’

 
• By 

The global allergy market is “expanding again but on new terms, driven by a mix of regional strength, evolving consumer behaviors, and an increasingly diverse competitive field,” according to the latest IQVIA Consumer Health analysis.

Japan Switches Rohto’s Algard Epinastine Eye Drops, Approves OTC Black Cohosh For Menopause

 
• By 

Japan’s Ministry of Health, Labor and Welfare continues to widen access to non-prescription medicines with another Rx-to-OTC switch – Rohto Algard Epinastine Eye Drops – and a direct OTC approval of Sato Pharmaceutical's Menofeminin (black cohosh) menopause treatment.

German OTC Market: Cough & Cold Launches From P&G, Angelini And Zentiva

 
• By 

P&G expands its WICK range with a new natural line of cough syrups; Angelini introduces a guideline-compliant Tantum Verde Duo throat spray; Zentiva adds a children’s fever product to its Ibuflam brand.


Has The Global Market For Consumer Digital Health Apps Plateaued?

 
• By 

In overall terms, yes, answers IQVIA's latest Digital Health Trends report. But the market for condition-specific apps, particularly if they combine this with a high-quality user experience and strong clinical evidence, is booming.

OTC Marketing Awards 2025 Shortlist Revealed

 
• By 

The shortlist has been revealed for the upcoming 30th Annual OTC Marketing Awards, which takes place on Thursday 20 November in London, UK.

Boots Shakes Up UK ED Market With Sildenafil Oral Film

 
• By 

UK health & beauty retailer Boots has partnered with IBSA to launch a "first of its kind" orodispersible non-prescription sildenafil option.

Women’s Health: Tranexamic Acid Now Available OTC In France

 
• By 

Cemag Care may be behind the recent Rx-to-OTC switch of menstrual health treatment tranexamic acid (1000mg) in France.


‘Where Life Is Experienced’ – Bayer And Karo On Winning In ‘Connected Commerce’

 
• By 

Bayer’s EMEA e-commerce and commercial director, Andrew Parker, and Karo Healthcare’s global skin health category director, Sally Perry, discuss how the consumer health industry can meet today's “connected consumers” on their omnichannel shopping journey.

Perrigo: Women’s Health Innovation Must Involve Women, Right From The Start

 
• By 

“Women's health isn't a niche area," noted Perrigo’s Alison Slingsby at Lynx2Market’s PharmaSynergyOTC event in Rome. Slingsby offers advice from the firm's experience in delivering some of the most innovative women's health Rx-to-OTC switches.

Gen Z Longevity Trend Offers Hope For Stagnating Global OTC Market

 
• By 

HBW Insight reports from the opening session of Lynx2Market’s PharmaSynergyOTC event in Rome, Italy, featuring IQVIA Consumer Health, Euromonitor International and Amazon.

Japan Approves OTC Sale Of Emergency Contraceptive Pill

 
• By 

Aska Pharmaceutical has recieved a green light from Japan’s Ministry of Health, Labour and Welfare for the Rx-to-OTC switch of its NorLevo (1.5mg levonorgestrel) emergency contraceptive. Controversially, OTC NorLevo will need to be taken on the spot by purchasers in the presence of a pharmacist.


Maxwellia Brings Pain Relief Alternative To UK Following Naproxen Switch

 
• By 

Thanks to a successful reclassification by Maxwellia, UK consumers have a new option for relief from musculoskeletal pain.

Opella Switches Cialis In Norway

 
• By 

Norway becomes the third European country to approve OTC sales of tadalafil. Cialis reseptfri will “soon be on shelves,” Opella says, with the launched being planned in partnership with Stada Arzneimittel.

German Pain And Cough Launches From Haleon, Bayer And Angelini

 
• By 

Haleon adds herbal pain relief to Voltaren topicals line, Bayer launches herbal expectorant in time for autumn and Angelini creates a throat spray that meets German Society for General Practice and Family Medicine guidelines.

Haleon Launches Paw Patrol Kids Aquafresh Toothbrush In The UK

 
• By 

UK children will be able to clean their teeth with Paw Patrol themed Aquafresh toothbrushes and toothpastes following launches from Haleon.